XPEL, Inc. current report, 29 December 2021

XPEL, Inc. — Form 8-K Summary

Business context and reporting period

XPEL, Inc., a Nevada corporation listed on Nasdaq under “XPEL,” filed a Form 8-K reporting a material financing amendment dated December 29, 2021. The report was signed on January 3, 2022. The filing does not cover quarterly or annual operating results.

Financing and key financial information

ItemFiling disclosure
Credit facilityLine of credit increased to $75 million from the original $57 million limit.
LenderTexas Partners Bank
AgreementFirst Amendment to the May 21, 2021 Loan Agreement
Other termsContractual terms and customary covenants remain unchanged, according to the filing.
Operating metricsThe filing does not provide revenue, profit, cash flow, margins, debt outstanding, liquidity balances, or utilization of the credit facility.

Material changes versus the prior comparable period

The material change disclosed is an $18 million increase in the borrowing limit, from $57 million to $75 million. No comparable-period operating or financial results are provided.

Outlook, risks, contingencies, and unusual items

  • The increased facility may provide additional borrowing capacity, but the filing does not state the intended use, current availability, amount drawn, interest rate, maturity, or repayment schedule.
  • The agreement retains customary covenants and related definitions. The filing does not describe covenant thresholds or compliance status.
  • The filing includes standard cautions that representations, warranties, and covenants were made for contractual purposes, are subject to agreed limitations and materiality standards, and should not be relied upon as broader factual characterizations of XPEL or its affiliates.

Investor verification checklist

  • Review Exhibit 10.1 for interest rates, maturity, collateral, borrowing conditions, covenants, events of default, and mandatory repayment provisions.
  • Verify the amount drawn and remaining availability under the $75 million facility in subsequent periodic filings.
  • Assess compliance with the unchanged covenants and any impact on liquidity and leverage.
  • Confirm whether the facility was used for acquisitions, working capital, capital expenditures, or other purposes.